Human Stem Cells Institute PJSC Logo

Human Stem Cells Institute PJSC

Develops gene therapies, vaccines, medical devices, and genetic testing systems.

ISKJ | MOEX

Overview

Corporate Details

ISIN(s):
RU000A0JNAB6
LEI:
Country:
Russian Federation
Address:
3 Gubkina Street PO Box 373, 119333  Moscow

Description

Artgen Biotech PJSC, formerly Human Stem Cells Institute PJSC, is a biotechnology company focused on developing and commercializing a portfolio of innovative biomedical technologies. The company's core activities include the research and development of gene therapy drugs, vaccines, and antibodies. It also creates medical devices using gene-activated materials for regenerative medicine and develops test systems for medical genetics. Additionally, Artgen Biotech offers services such as biobanking of cord blood stem cells, genetic research, and regenerative medicine applications based on cellular technologies. The company operates as a strategic investor and an ecosystem to accelerate biotech developments from research to clinical practice.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Human Stem Cells Institute PJSC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Human Stem Cells Institute PJSC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Human Stem Cells Institute PJSC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.